Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1975 1
1976 2
1977 3
1978 2
1980 1
1981 2
1983 5
1984 7
1985 2
1986 2
1987 3
1988 2
1989 7
1990 5
1991 3
1992 5
1993 5
1994 5
1995 1
1996 6
1997 5
1998 1
2000 6
2001 4
2002 3
2003 4
2004 4
2005 8
2006 2
2007 5
2008 6
2009 3
2010 4
2011 2
2012 2
2013 3
2014 2
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG. Stein JP, et al. J Clin Oncol. 2001 Feb 1;19(3):666-75. doi: 10.1200/JCO.2001.19.3.666. J Clin Oncol. 2001. PMID: 11157016 Corrected and republished.
PURPOSE: To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node dissection for invasive bladder cancer and to describe the association of the primary bladder tumor stage and regional lymph node status with …
PURPOSE: To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node dissection for i …
Dilemmas in the treatment of urothelial cancers of the prostate.
Walsh DL, Chang SS. Walsh DL, et al. Urol Oncol. 2009 Jul-Aug;27(4):352-7. doi: 10.1016/j.urolonc.2007.12.010. Epub 2008 Apr 24. Urol Oncol. 2009. PMID: 18439852 Review.
Bibliographies of reviewed articles were also searched. RESULTS: Transitional cell carcinoma of the bladder with involvement of the prostate has been reported in multiple studies with an incidence between 12% and 48%. Stromal invasion of the prostate h …
Bibliographies of reviewed articles were also searched. RESULTS: Transitional cell carcinoma of the bladder with …
Management of advanced bladder cancer in patients with impaired renal function.
Bournakis E, Dimopoulos MA, Bamias A. Bournakis E, et al. Expert Rev Anticancer Ther. 2011 Jun;11(6):931-9. doi: 10.1586/era.10.197. Expert Rev Anticancer Ther. 2011. PMID: 21707290 Review.
Advanced transitional-cell carcinoma of the bladder is the most common cancer of the urinary tract, with a high mortality rate. ...The study of newer targeted therapies in the treatment of bladder cancer is also discussed, as are future p …
Advanced transitional-cell carcinoma of the bladder is the most common cancer of the urinary tract, with a high …
Gemcitabine in the treatment of bladder cancer.
Ryan CW, Vogelzang NJ. Ryan CW, et al. Expert Opin Pharmacother. 2000 Mar;1(3):547-53. doi: 10.1517/14656566.1.3.547. Expert Opin Pharmacother. 2000. PMID: 11249537 Review.
New agents are available for the treatment of metastatic transitional cell carcinoma of the bladder. In the US, the combination of methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) remains the standard chemotherapy regimen for advanced bl …
New agents are available for the treatment of metastatic transitional cell carcinoma of the bladder. In the US, …
Current recommendations for the management of bladder cancer. Drug therapy.
Witjes JA. Witjes JA. Drugs. 1997 Mar;53(3):404-14. doi: 10.2165/00003495-199753030-00005. Drugs. 1997. PMID: 9074842 Review.
Superficial transitional cell carcinoma of the bladder is a heterogeneous group of tumours, and prediction of disease outcome in an individual patient is still impossible. ...For both, however, efficacy still needs to be proven, and results of ongoing …
Superficial transitional cell carcinoma of the bladder is a heterogeneous group of tumours, and prediction of di …
Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
Mak RH, Zietman AL, Heney NM, Kaufman DS, Shipley WU. Mak RH, et al. BJU Int. 2008 Nov;102(9 Pt B):1345-53. doi: 10.1111/j.1464-410X.2008.07981.x. BJU Int. 2008. PMID: 19035903 Review.
While radical cystectomy (RC) remains the standard of care for muscle-invasive transitional cell carcinoma of the bladder, a series of single-institution and cooperative-group trials with a long-term follow-up have shown that combined modality …
While radical cystectomy (RC) remains the standard of care for muscle-invasive transitional cell carcinoma of th …
Radical transurethral resection in the management of muscle-invasive bladder cancer.
Grob BM, Macchia RJ. Grob BM, et al. J Endourol. 2001 May;15(4):419-23; discussion 425-6. doi: 10.1089/089277901300189475. J Endourol. 2001. PMID: 11394456 Review.
The morbidity of radical cystectomy and early reports of good results have stimulated interest in radical transurethral resection of bladder tumors (TURBT) for muscle-invasive transitional-cell carcinoma of the bladder. ...Further research is ne …
The morbidity of radical cystectomy and early reports of good results have stimulated interest in radical transurethral resection of blad …
Diagnosis and treatment of superficial transitional cell carcinoma of the bladder: facts and perspectives.
Kurth KH. Kurth KH. Eur Urol. 1997;31 Suppl 1:10-9. doi: 10.1159/000474526. Eur Urol. 1997. PMID: 9076481 Review.
The detection of potentially highly curable low-grade bladder cancers by noninvasive techniques remains an unsolved problem. Conventional cytology detects such tumors with 50% sensitivity, the addition of DNA image analysis cytometry in patients with previous transition …
The detection of potentially highly curable low-grade bladder cancers by noninvasive techniques remains an unsolved problem. Conventi …
Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.
Garcia JA, Dreicer R. Garcia JA, et al. Nat Clin Pract Urol. 2005 Jan;2(1):32-7. doi: 10.1038/ncpuro0068. Nat Clin Pract Urol. 2005. PMID: 16474574 Review.
Transitional cell carcinoma of the bladder is sensitive to chemotherapy. ...With the introduction of new cytotoxic drugs and novel small molecules, there is a need for well-designed studies to address the optimal utility of perioperative therapy …
Transitional cell carcinoma of the bladder is sensitive to chemotherapy. ...With the introduction of new cytotox …
Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience.
Colombo R, Salonia A, Da Pozzo LF, Naspro R, Freschi M, Paroni R, Pavone-Macaluso M, Rigatti P. Colombo R, et al. Crit Rev Oncol Hematol. 2003 Aug;47(2):127-39. doi: 10.1016/s1040-8428(03)00076-3. Crit Rev Oncol Hematol. 2003. PMID: 12900006 Review.
The prevalence of superficial transitional cell carcinoma of the bladder (STCCB) is still increasing in spite of improved adjuvant chemotherapeutic and/or immunoprophylaxis approaches. ...In particular, a synergistic or, at least, supra-additive anti-t …
The prevalence of superficial transitional cell carcinoma of the bladder (STCCB) is still increasing in spite of …
129 results